Advanced search

380 Results

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Transcript : Voyager Therapeutics, Inc., Q2 2023 Earnings Call, Aug 03, 2023	03/08/23
Voyager Therapeutics Reports Second Quarter 2023 Financial and Operating Results	03/08/23	AQ
Transcript : Voyager Therapeutics, Inc., Q1 2023 Earnings Call, May 09, 2023	09/05/23
VOYAGER THERAPEUTICS, INC. : Change in Directors or Principal Officers (form 8-K)	09/05/23	AQ
Voyager Therapeutics Reports First Quarter 2023 Financial and Operating Results	09/05/23	AQ
Voyager Therapeutics Announces Appointment of George Scangos, Ph.D., to Board of Directors	09/05/23	AQ
Voyager Therapeutics, Inc. Appoints George Scangos as Director and as Member of Science and Technology Committee	09/05/23	CI
Vir Biotechnology Provides Corporate Update and Reports First Quarter 2023 Financial Results	04/05/23	GL
AGILENT TECHNOLOGIES, INC. : Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K)	17/03/23	AQ
Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2022 Financial Results	23/02/23	GL
Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2022 Financial Results	23/02/23	AQ
Vir Biotechnology Announces Positive Final Draft Guidance on Sotrovimab from the UK's National Institute for Health and Care Excellence	23/02/23	AQ
Vir Biotechnology Announces Positive Final Draft Guidance on Sotrovimab from the UK’s National Institute for Health and Care Excellence (NICE)	22/02/23	GL
Vir Biotechnology Announces Positive Final Draft Guidance on Sotrovimab from the UK’s National Institute for Health and Care Excellence (NICE)	22/02/23	AQ
Vir Biotechnology Appoints Sung Lee as Chief Financial Officer	16/02/23	GL
Vir Biotechnology Appoints Sung Lee as Chief Financial Officer	16/02/23	AQ
Vir Biotechnology Announces Amended Collaboration Agreement with GSK	13/02/23	GL
Vir Biotechnology Announces Amended Collaboration Agreement with GSK	13/02/23	GL
VIR BIOTECHNOLOGY, INC. : Change in Directors or Principal Officers (form 8-K)	25/01/23	AQ
Vir Biotechnology Announces Retirement of CEO George Scangos, Ph.D.; Appoints Marianne De Backer, MSc, Ph.D., MBA, as Successor	25/01/23	GL
Vir Biotechnology Announces Retirement of CEO George Scangos, Ph.D.; Appoints Marianne De Backer, MSc, Ph.D., MBA, as Successor	25/01/23	AQ
Vir Biotechnology, Inc. Announces CEO Changes	25/01/23	CI
Transcript : Vir Biotechnology, Inc. Presents at 41st Annual J.P. Morgan Healthcare Conference, Jan-10-2023 09:45 AM	10/01/23
Vir Biotechnology to Highlight Anticipated 2023 Catalysts and Long-Term Growth Strategy at 41st Annual J.P. Morgan Healthcare Conference	03/01/23	GL
Vir Biotechnology Ranked the Fastest-Growing Company in North America on the 2022 Deloitte Technology Fast 500	17/11/22	AQ
Vir Biotechnology Ranked the Fastest-Growing Company in North America on the 2022 Deloitte Technology Fast 500™	16/11/22	GL
Vir Biotechnology Ranked the Fastest-Growing Company in North America on the 2022 Deloitte Technology Fast 500™	16/11/22	AQ
Vir Biotechnology Provides Corporate Update and Reports Third Quarter 2022 Financial Results	03/11/22	GL
Vir Biotechnology Provides Corporate Update and Reports Third Quarter 2022 Financial Results	03/11/22	AQ
Vir Biotech gets U.S. funding for flu-prevention antibody	04/10/22	RE
Vir Biotechnology : Provides Corporate Update and Reports Second Quarter 2022 Financial Results - Form 8-K	09/08/22	PU
Vir Biotechnology Provides Corporate Update and Reports Second Quarter 2022 Financial Results	09/08/22	GL
Vir Biotechnology Announces Transition of Chief Scientific Officer	14/07/22	GL
Vir Biotechnology Announces Transition of Chief Scientific Officer	14/07/22	GL
VIR BIOTECHNOLOGY, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)	24/05/22	AQ
Vir Biotechnology Provides Corporate Update and Reports First Quarter 2022 Financial Results	05/05/22	GL
Vir Biotechnology Provides Corporate Update and Reports First Quarter 2022 Financial Results	05/05/22	AQ
Transcript : Vir Biotechnology, Inc. - Special Call	27/04/22
Vir Biotechnology Announces New Data From the MARCH Hepatitis B Trial, Unveils New Hepatitis D Clinical Program and Highlights Broad Hepatitis Portfolio at Virtual Hepatitis Portfolio R&D Day	27/04/22	GL
Vir Biotechnology Announces New Data From the MARCH Hepatitis B Trial, Unveils New Hepatitis D Clinical Program and Highlights Broad Hepatitis Portfolio at Virtual Hepatitis Portfolio R&D Day	27/04/22	GL
Vir Biotechnology to Host a Virtual Hepatitis Portfolio R&D Day	13/04/22	AQ
Vir Biotechnology Scientists Named Winners of the BARDA and HHS-Sponsored Pediatric COVID-19 Data Challenge	06/04/22	GL
AGILENT TECHNOLOGIES, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)	17/03/22	AQ
Vir Biotechnology : Provides Corporate Update and Reports Fourth Quarter and Full Year 2021 Financial Results - Form 8-K	24/02/22	PU
Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2021 Financial Results	24/02/22	AQ
Data Suggest Sotrovimab Retains Neutralizing Activity Against Omicron Subvariant BA.2	10/02/22	GL
Vir Biotechnology Appoints Johanna Friedl-Naderer as Executive Vice President and Chief Business Officer, Global	08/02/22	GL
Vir Biotechnology Appoints Johanna Friedl-Naderer as Executive Vice President and Chief Business Officer, Global	08/02/22	AQ
Vir Biotechnology, Inc. Appoints Johanna Friedl-Naderer as Executive Vice President and Chief Business Officer, Global, Effective March 2, 2022	08/02/22	CI
Vir Biotechnology Launches New Antibody Research Initiative Aimed at a Functional Cure for HIV and Prevention of Malaria	13/01/22	GL

No results for this search

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

BENEFIT NOW